Poolbeg Pharma PLC (POLB.L)
Poolbeg Pharma PLC, a clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom.
6.80+0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+151.9%
The outlook
Poolbeg Pharma PLC currently reads as bullish based on strong buy — 1.0 avg of 1 analysts, above its 50- & 200-day averages, 66% of the way from its 52-week low to high, avg target +179% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendAbove its 50- & 200-day averages
52-week range66% of the way from its 52-week low to high
Price targetAvg target +179% vs current price
Market cap
$51.9M
52-wk high
9.00
52-wk low
2.50
50-day avg
6.80
200-day avg
4.88
Trailing P/E
—